LifeScan Defective SureStep Glucose Meter Civil Trial Slated For September
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson subsidiary LifeScan will remain on probation for a three-year period, during which FDA and the U.S. Probation Office will oversee the firm's documentation of medical device reporting (MDR) complaints.
You may also be interested in...
Guidant/DoJ Probe Details Postmarket Reporting Meltdown With AAA Device
A settlement between Guidant and the Department of Justice over deficient medical device reporting of deaths and serious injuries, combined with public awareness of the lapses, sets the stage for closer scrutiny of MDR practices across the industry
Guidant/DoJ Probe Details Postmarket Reporting Meltdown With AAA Device
A settlement between Guidant and the Department of Justice over deficient medical device reporting of deaths and serious injuries, combined with public awareness of the lapses, sets the stage for closer scrutiny of MDR practices across the industry
LifeScan $45 Mil. Glucose Meter Settlement Approval Hearing Set For Dec. 10
Johnson & Johnson/LifeScan's $45 mil. class action settlement with purchasers of defective SureStep blood glucose meters is set for a preliminary approval hearing Dec. 10 in San Jose, California federal court